All articles
Mind Lab Pro Clinical Trials Delayed Recall Memory
6 min readMay 5, 2026

Mind Lab Pro Clinical Trials Delayed Recall Memory

Analyze 30/60-day trial results on immediate/delayed recall, brain connectivity, compare to competitors like Noocube

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new supplement regimen.

Introduction: Understanding Delayed Recall and Nootropic Research

Delayed recall is a cognitive metric used to measure the ability to retrieve information after a period of distraction or a delay in time. In the context of neuropsychological testing, it serves as a key indicator of memory consolidation and retrieval efficiency. For those researching mind lab pro clinical trials delayed recall memory, it is important to understand that these trials are designed to evaluate whether a specific supplement formula can influence performance on standardized tests, such as the Wechsler Memory Scale (WMS-IV UK) [2].

Clinical trials in the nootropic space aim to bridge the gap between anecdotal reports and objective scientific data. While many supplements rely on individual ingredient studies, high-quality research focuses on the finished product to determine if the synergistic combination of ingredients produces a measurable effect. When evaluating these trials, it is essential to distinguish between laboratory performance on specific tasks and real-world cognitive improvement.

The Cognitive Mechanism: What is Delayed Recall?

Delayed recall is a component of episodic memory. It refers to the process of accessing stored information after an interval—typically 20 to 30 minutes—during which the participant is occupied with other tasks. This metric helps researchers understand how well the brain encodes, stores, and retrieves verbal or visual information.

In healthy adults, delayed recall can be influenced by various factors, including sleep quality, stress levels, baseline nutritional status, and age. Nootropic research often targets this specific memory domain because it is highly sensitive to cognitive fatigue and mental strain. By assessing performance through standardized memory tests, researchers attempt to quantify whether a supplement can assist in maintaining cognitive function under testing conditions.

Analyzing the Mind Lab Pro Clinical Data

The clinical evidence for Mind Lab Pro is primarily derived from an independent, double-blind, placebo-controlled randomized trial conducted at the University of Leeds [2][3]. This study design is considered the "gold standard" in clinical research because it minimizes bias by ensuring that neither the researchers nor the participants know who is receiving the active supplement and who is receiving the placebo. It should be noted that this research was funded by the manufacturer, a factor that should be considered when evaluating potential industry bias in the study design or reporting.

The study enrolled 49 healthy adults, with a mean age of approximately 31 years [2]. Participants were assessed using the WMS-IV UK, a comprehensive neuropsychological tool [2]. The research focused on measuring changes in memory performance over a 30-day supplementation period [2].

Study Outcomes: Immediate vs. Delayed Recall Improvements

The data from the University of Leeds trial indicated statistically significant differences in memory subtests for the experimental group compared to the placebo group [2][3]. The findings are summarized in the table below:

MetricObserved Change (Experimental Group)Statistical Context
Delayed Recall26%p < 0.05 (Significant) [1]
Immediate Recall28%p < 0.05 (Significant) [1]

While these figures represent a notable shift in test scores, it is important to interpret them with caution. The p-values indicate that the results were statistically significant within the context of this specific study; however, the sample size of 49 participants is relatively small [2]. Small sample sizes can sometimes lead to results that may not be fully representative of the broader population. Furthermore, the 30-day duration of the study limits our understanding of whether these cognitive changes persist over months or years of consistent use [2].

Ingredient-Level vs. Formula-Level Evidence

A common point of confusion in nootropic research is the difference between ingredient-level efficacy and formula-level efficacy. Many products contain ingredients like Bacopa monnieri or Citicoline, which have been studied extensively in isolation [3].

  • Ingredient-Level Evidence: This refers to individual clinical trials on a single compound. For example, Bacopa monnieri has been studied for its potential to support memory and cognitive processing speed.
  • Formula-Level Evidence: This refers to trials conducted on the specific, finished product containing a blend of ingredients.

The Mind Lab Pro trial is notable because it tested the finished formula [2]. However, it is important to remember that the efficacy of a formula is not merely the sum of its parts. Interactions between ingredients, the specific dosages used, and the quality of the raw materials all play a role in the final outcome. Relying on ingredient-level data to predict the success of a full stack can be misleading, as the clinical evidence for the specific formula is what ultimately determines its performance in a trial setting.

Limitations of Current Nootropic Clinical Research

When reviewing the clinical data for any nootropic, including Mind Lab Pro, it is necessary to address the inherent limitations of the current research landscape.

  1. Sample Size: With only 49 participants, the University of Leeds study lacks the statistical power of larger, multi-site trials [2]. Larger studies are typically required to confirm that findings are consistent across diverse demographics.
  2. Duration: A 30-day window provides a snapshot of short-term cognitive changes [2]. It does not offer insight into the long-term safety profile or the potential for a "plateau" effect, where cognitive benefits might level off after the initial period of supplementation.
  3. Ecological Validity: Standardized tests like the WMS-IV are excellent for controlled laboratory environments [2]. However, they may not perfectly mirror the complex memory demands of daily life, such as remembering a list of tasks at work or recalling information during a high-stress social interaction.
  4. Lack of Independent Replication: While the initial study was independent, the broader scientific community generally requires multiple, independent replications of a study before a finding is considered widely accepted.

Safety, Regulatory Status, and Regional Variability

Mind Lab Pro is classified as a dietary supplement [6]. In the United States, this means it is regulated under the Dietary Supplement Health and Education Act (DSHEA) [6]. Under this framework, the product is not required to undergo the same rigorous pre-market approval process as pharmaceutical drugs [1].

Safety and Adverse Events

The provided research materials do not contain comprehensive pharmacovigilance data or systematic reports on adverse events. While no serious safety concerns were highlighted in the available studies, the absence of data does not equate to a total absence of risk.

Regulatory Considerations

Regulatory status varies by region:

  • United States: Marketed under DSHEA; not intended to treat or cure disease [6].
  • United Kingdom/EU: Must adhere to local food supplement regulations. Health claims must be authorized by relevant food safety authorities.
  • Canada/Australia: Products must meet specific safety and quality standards set by national health agencies (e.g., Health Canada or the TGA).

Because regulatory oversight for supplements is less stringent than for prescription medications, users should be aware that the quality, purity, and safety monitoring of these products can vary. Individuals who are pregnant, nursing, taking prescription medications (especially those affecting the central nervous system), or those with pre-existing medical conditions should consult a healthcare provider before starting any new supplement regimen. It is important to emphasize that these studies were conducted on healthy adults; the safety and efficacy of this product for individuals with diagnosed cognitive impairment or neurodegenerative conditions have not been established.

Conclusion: Balancing Scientific Evidence with Realistic Expectations

The research surrounding Mind Lab Pro and delayed recall memory offers a look at how a multi-ingredient stack might influence cognitive performance in healthy adults. The University of Leeds study provides moderate-quality evidence that the formula is associated with measurable changes in memory recall tasks over a 30-day period [2][3].

However, it is vital to maintain a balanced perspective. The current evidence is limited by a small sample size, a short study duration, and a lack of long-term safety data. These findings should be viewed as preliminary rather than definitive. When considering the use of nootropics, it is best to approach them as a potential support for a healthy lifestyle—which includes adequate sleep, balanced nutrition, and regular mental exercise—rather than a substitute for foundational health habits.

Always consult with a qualified healthcare professional to discuss your individual health needs, potential contraindications with other medications, and whether a supplement is appropriate for your specific circumstances. By combining a cautious, evidence-based approach with realistic expectations, you can make more informed decisions regarding your cognitive health.

References

  1. FDA: Information on Dietary Supplements
  2. Human Psychopharmacology: Clinical and Experimental Study
  3. PubMed: Research on Nootropic Efficacy
  4. Mind Lab Pro: Summary of Clinical Research